相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quorum sensing architecture network in Escherichia coli virulence and pathogenesis
Celia Mayer et al.
FEMS MICROBIOLOGY REVIEWS (2023)
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant enterobacterales
Maxime Danjean et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Young-A. Heo
DRUGS (2021)
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
Shu-Chen Kuo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
Katherine Young et al.
BMC MICROBIOLOGY (2019)
Inoculum effect of β-lactam antibiotics
Justin R. Lenhard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options
Gisele Peirano et al.
DRUGS (2019)
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a beta-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
Elizabeth G. Rhee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Rapid Screening of Urinary Tract Infection and Discrimination of Gram-Positive and Gram-Negative Bacteria by Automated Flow Cytometric Analysis Using Sysmex UF-5000
Seon Young Kim et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
William R. Miller et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae
Darren Wong et al.
VIRULENCE (2017)
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
Matthew Sims et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)
Sibylle H. Lob et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
Christopher Lucasti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2016)
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli et al.
LANCET INFECTIOUS DISEASES (2016)
Population Density Modulates Drug Inhibition and Gives Rise to Potential Bistability of Treatment Outcomes for Bacterial Infections
Jason Karslake et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Avibactam Alone and in Combination with Ceftazidime in Healthy Male Volunteers: Results of Two Randomized, Placebo-Controlled Studies
Henri Merdjan et al.
CLINICAL DRUG INVESTIGATION (2015)
Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease
Huaying Wang et al.
BMC PULMONARY MEDICINE (2015)
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
David E. Ehmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates
L. Lopez-Cerero et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Killing of Escherichia coli by beta-lactams at different inocula
Vincent H. Tam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Functional relationship between bacterial cell density and the efficacy of antibiotics
Klas I. Udekwu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins
Carmen Betriu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology
AM Queenan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Differential antibiotic-induced endotoxin release in severe melioidosis
AJH Simpson et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
